Compare IDEXX Laboratories, Inc. (IDXX) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Wolfspeed Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Wolfspeed Inc trades at $30.35 (market cap $1.64B). The key difference: IDEXX Laboratories, Inc. is far larger — about 24.7× Wolfspeed Inc's market cap, and Wolfspeed Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Wolfspeed Inc for 19 Days on average.
| IDXX | WOLF | |
|---|---|---|
Market Cap | $40.43B | $1.64B |
Volume | 692,164 | 22,772,687 |
Sector | Health | Technology |
52-Week High | $766.68 | $73.68 |
52-Week Low | $504.70 | $14.80 |
Typical Hold Time | 46 Days | 19 Days |
Enterprise Value | $41.32B | $2.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Wolfspeed (WOLF) trades at $30.54, down 2.65% on the day, with a bullish technical signal from moving averages. The company shows improving quarterly performance with recent EPS beats, though 2025 financials reveal significant losses with negative gross margins. Recent news highlights expansion of 200mm silicon carbide technology and ongoing investor investigations.
The stock presents a high-risk opportunity with analyst consensus target of $54.32 suggesting 78% upside potential. Key risks include persistent negative profitability, ongoing legal investigations, and the challenge of achieving revenue growth sufficient for margin improvement. Success depends on execution of silicon carbide market expansion and AI infrastructure demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
